TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced ...
SPPADE symptom burden and ePRO-based outcome prediction in patients with mCRPC treated with 177Lu-PSMA-617 (LuPSMA). Bone fractures with androgen pathway inhibitors (ARPi) in patients (pts) with ...
TORONTO - A new study led by researchers at the University of Toronto's Leslie Dan Faculty of Pharmacy and Unity Health Toronto shows that almost one quarter of hospital-treated opioid toxicities ...
Morning Overview on MSN
High-dose vitamin D can raise toxicity risks, Harvard Health warns
In April 2026, a walk down the supplement aisle at any major pharmacy tells a striking story: vitamin D capsules containing 5,000 IU, 10,000 IU, and even 50,000 IU sit on shelves alongside ...
CytoAgents Inc. completed the dose-limiting toxicity observation for the first cohort in a trial targeting CRS in blood cancer patients. The Safety Review Committee approved dose escalation for the ...
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study. Using data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results